Literature DB >> 32218668

Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review.

P Holland1, J Merrimen2, C Pringle3, L A Wood4,5.   

Abstract

Renal medullary carcinoma (rmc) is a rare and aggressive renal malignancy that usually presents at an advanced stage, has a poor prognosis, and is associated with sickle cell trait. We present a case of rmc including radiologic and pathology findings, treatment, and outcome. A review of the literature is also presented, with an emphasis on the association of rmc with sickle cell trait, which was an unknown diagnosis in our patient preoperatively. 2020 Multimed Inc.

Entities:  

Keywords:  Renal medullary carcinoma; kidney cancer; sickle cell disease

Mesh：

Year:  2020        PMID： 32218668      PMCID： PMC7096200          DOI： 10.3747/co.27.5043

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


  9 in total

1.  Renal Medullary Carcinoma: The Kidney Cancer That Affects Individuals With Sickle Cell Trait and Disease.

Authors:  Ofelia A Alvarez
Journal:  J Oncol Pract       Date:  2017-07       Impact factor: 3.840

2.  Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.

Authors:  Mahul B Amin; Steven C Smith; Abbas Agaimy; Pedram Argani; Eva Marie Compérat; Brett Delahunt; Jonathan I Epstein; John N Eble; David J Grignon; Arndt Hartmann; Ondřej Hes; Michelle S Hirsch; Rafael E Jimenez; Lakshmi P Kunju; Guido Martignoni; Jesse K McKenney; Holger Moch; Rodolfo Montironi; Gladell P Paner; Priya Rao; John R Srigley; Satish K Tickoo; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

Review 3.  Renal Medullary Carcinoma: Establishing Standards in Practice.

Authors:  Kathryn E Beckermann; Deva Sharma; Shruti Chaturvedi; Pavlos Msaouel; Miguel R Abboud; Yves Allory; Franck Bourdeaut; Julien Calderaro; Aguirre A de Cubas; Vimal K Derebail; Andrew L Hong; Rakhi P Naik; Gabriel G Malouf; Elizabeth A Mullen; Victor E Reuter; Charles W M Roberts; Cheryl L Walker; Christopher G Wood; Michael R DeBaun; Hendrik Van Poppel; Nizar M Tannir; W Kimryn Rathmell
Journal:  J Oncol Pract       Date:  2017-07       Impact factor: 3.840

Review 4.  A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.

Authors:  Pavlos Msaouel; Nizar M Tannir; Cheryl Lyn Walker
Journal:  Clin Cancer Res       Date:  2018-02-12       Impact factor: 12.531

5.  Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.

Authors:  Amishi Y Shah; Jose A Karam; Gabriel G Malouf; Priya Rao; Zita D Lim; Eric Jonasch; Lianchun Xiao; Jianjun Gao; Ulka N Vaishampayan; Daniel Y Heng; Elizabeth R Plimack; Elizabeth A Guancial; Chunkit Fung; Stefanie R Lowas; Pheroze Tamboli; Kanishka Sircar; Surena F Matin; W Kimryn Rathmell; Christopher G Wood; Nizar M Tannir
Journal:  BJU Int       Date:  2016-12-09       Impact factor: 5.588

6.  Clinical outcome and prognostic factors in renal medullary carcinoma: A pooled analysis from 18 years of medical literature.

Authors:  Roberto Iacovelli; Daniela Modica; Antonella Palazzo; Patrizia Trenta; Gabriele Piesco; Enrico Cortesi
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

Review 7.  Renal medullary carcinoma and sickle cell trait: A systematic review.

Authors:  Ofelia Alvarez; Maria M Rodriguez; Lanetta Jordan; Sharada Sarnaik
Journal:  Pediatr Blood Cancer       Date:  2015-06-05       Impact factor: 3.167

8.  Renal medullary carcinoma. The seventh sickle cell nephropathy.

Authors:  C J Davis; F K Mostofi; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394

Review 9.  Imaging of Renal Medullary Carcinoma.

Authors:  Federico Greco; Eliodoro Faiella; Domiziana Santucci; Carlo Augusto Mallio; Marco Nezzo; Carlo Cosimo Quattrocchi; Bruno Beomonte Zobel; Rosario Francesco Grasso
Journal:  J Kidney Cancer VHL       Date:  2017-03-21
  9 in total
  2 in total

Review 1.  Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement.

Authors:  Osama Y Safdar; Rana M Baghdadi; Sereen A Alahmadi; Bana E Fakieh; Amaal M Algaydi
Journal:  World J Clin Pediatr       Date:  2022-01-09

Review 2.  SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities.

Authors:  Garrett W Cooper; Andrew L Hong
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.